East Marietta Drug Company
Form 483 issued August 23, 2019 · Marietta, Georgia
- Inspection
- Aug 19 – Aug 23, 2019
- Investigators
- Gideon N. Esuzor· Johnetta F. Walters
- Observations
- 3
- Pages
- 2
- FEI number
- 3012263025
In short: On August 23, 2019, FDA issued a Form 483 with 3 observations to East Marietta Drug Company in Marietta, Georgia (FEI 3012263025) after an inspection that ran Aug 19 – Aug 23, 2019. The investigators were Gideon N. Esuzor and Johnetta F. Walters.
What FDA observed
Preview: the opening words of each observation- 01FDCA 501(a)(2)(A)
You produced highly potent drugs without providing adequate cleaning of work…
- 02FDCA 501(a)(2)(A)
Personnel did not disinfect and change gloves frequently…
- 03FDCA 501(a)(2)(A)
Non-microbial contamination was observed in…
This inspection in context
Gideon N. Esuzor
3 documents · 2019
Cites FDCA 501(a)(2)(A) (insanitary conditions) more than any other section. Most of their documents are for sites in Georgia.
The firmEast Marietta Drug Company history
The site's inspection history, in date order.
Similar 483sMore form 483s
Browse other documents of this type.
Questions about this 483
What did FDA find at East Marietta Drug Company?
FDA listed 3 observations on this Form 483. The opening words of each observation are shown on this page.
Who inspected East Marietta Drug Company?
Gideon N. Esuzor and Johnetta F. Walters are named on this Form 483, for the inspection of Aug 19 – Aug 23, 2019. Each investigator has a profile showing what they cite most.
When was East Marietta Drug Company inspected by FDA?
The inspection ran Aug 19 – Aug 23, 2019, and the Form 483 is dated August 23, 2019.
How do I get the full Form 483 for East Marietta Drug Company?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.